Oral 4-aminopyridine(4-AP)is clinically used for symptomatic relief in multiple sclerosis and we recently demonstrated that systemic 4-AP had previously unknown clinically-relevant effects after traumatic peripheral n...Oral 4-aminopyridine(4-AP)is clinically used for symptomatic relief in multiple sclerosis and we recently demonstrated that systemic 4-AP had previously unknown clinically-relevant effects after traumatic peripheral nerve injury including the promotion of re-myelination,improvement of nerve conductivity,and acceleration of functional recovery.We hypothesized that,instead of oral or injection administration,transdermal 4-AP(TD-4-AP)could also improve functional recovery after traumatic peripheral nerve injury.Mice with surgical traumatic peripheral nerve injury received TD-4AP or vehicle alone and were examined for skin permeability,pharmacokinetics,functional,electrophysiological,and nerve morphological properties.4-AP showed linear pharmacokinetics and the maximum plasma 4-AP concentrations were proportional to TD-4-AP dose.While a single dose of TD-4-AP administration demonstrated rapid transient improvement in motor function,chronic TD-4-AP treatment significantly improved motor function and nerve conduction and these effects were associated with fewer degenerating axons and thicker myelin sheaths than those from vehicle controls.These findings provide direct evidence for the potential transdermal applicability of 4-AP and demonstrate that 4-AP delivered through the skin can enhance in-vivo functional recovery and nerve conduction while decreasing axonal degeneration.The animal experiments were approved by the University Committee on Animal Research(UCAR)at the University of Rochester(UCAR-2009-019)on March 31,2017.展开更多
The effect of 2-butyne-1, 4-diol on silver electrodeposition process from 5, 5-dimethyl hydantoin solutions was investigated by means of cyclic voltammetric measurement, scanning electron microscopy (SEM) and X-ray di...The effect of 2-butyne-1, 4-diol on silver electrodeposition process from 5, 5-dimethyl hydantoin solutions was investigated by means of cyclic voltammetric measurement, scanning electron microscopy (SEM) and X-ray diffraction (XRD). Cyclic voltammetric studies indicate that the reduction process of silver electrodeposition is influenced by adding 2-butyne-1, 4-diol. Owing to its adsorption on the electrode surface, 2-butyne-1, 4-diol moderately hinders the mass transfer of the silver complexed ions from the bulk solution to the outer limit of the electrode double layer and affects the electrocrystallization step. Scanning electron microscopy analysis reveals that the presence of 2-butyne-1, 4-diol in the electrolyte is beneficial and the silver deposits obtained are smoother, more compact and more leveled. X-ray diffraction analysis of the silver deposits obtained at 0.5 g·L-1 2-butyne-1, 4-diol indicated that the (110) plane is the most preferred plane and is not affected by the presence of 2-butyne-1, 4-diol in the electrolyte.展开更多
The title compound N1-(2-(4-bromo-2-nitrophenoxy)-2-dimethyl acyloxymethyl)-5-fluorouracil(C15H13BrFN3O7, Mr = 446.19) was synthesized and structurally characterized by ^1H-NMR, -(13)C-NMR, ESI-MS and single-c...The title compound N1-(2-(4-bromo-2-nitrophenoxy)-2-dimethyl acyloxymethyl)-5-fluorouracil(C15H13BrFN3O7, Mr = 446.19) was synthesized and structurally characterized by ^1H-NMR, -(13)C-NMR, ESI-MS and single-crystal X-ray diffraction. The compound crystallizes in triclinic, space group P1, with a = 8.3325(6), b = 10.1808(13), c = 11.8194(16) A, α = 73.194(12), β= 72.351(9), γ = 89.509(8)o, V = 911.2(2) A^3, Z = 2, T = 300.79(10) K, μ(Cu Kα) = 3.578 mm^-1, Dc = 1.626 g/cm3, F(000) = 448.0, GOF = 1.060, 5723 reflections measured(8.232≤2θ≤139.592°), 3339 unique(Rint = 0.0184, Rsigma = 0.0254) which were used in all calculations. The final R = 0.0517(I 〉 2s(I)) and wR = 0.1494(all data). Hydrogen bonds and π-π interactions together stabilize the structure of the molecule. The preliminary biological test shows that the title compound has good antitumor activity against A549 in vitro and lower toxicity to normal cells.展开更多
基金supported by grants from the National Institutes of Health(K08 AR060164-01A)Department of Defense(W81XWH-16-1-0725)to JCE in addition to institutional support from the University of Rochester and Pennsylvania State University Medical Centers
文摘Oral 4-aminopyridine(4-AP)is clinically used for symptomatic relief in multiple sclerosis and we recently demonstrated that systemic 4-AP had previously unknown clinically-relevant effects after traumatic peripheral nerve injury including the promotion of re-myelination,improvement of nerve conductivity,and acceleration of functional recovery.We hypothesized that,instead of oral or injection administration,transdermal 4-AP(TD-4-AP)could also improve functional recovery after traumatic peripheral nerve injury.Mice with surgical traumatic peripheral nerve injury received TD-4AP or vehicle alone and were examined for skin permeability,pharmacokinetics,functional,electrophysiological,and nerve morphological properties.4-AP showed linear pharmacokinetics and the maximum plasma 4-AP concentrations were proportional to TD-4-AP dose.While a single dose of TD-4-AP administration demonstrated rapid transient improvement in motor function,chronic TD-4-AP treatment significantly improved motor function and nerve conduction and these effects were associated with fewer degenerating axons and thicker myelin sheaths than those from vehicle controls.These findings provide direct evidence for the potential transdermal applicability of 4-AP and demonstrate that 4-AP delivered through the skin can enhance in-vivo functional recovery and nerve conduction while decreasing axonal degeneration.The animal experiments were approved by the University Committee on Animal Research(UCAR)at the University of Rochester(UCAR-2009-019)on March 31,2017.
文摘The effect of 2-butyne-1, 4-diol on silver electrodeposition process from 5, 5-dimethyl hydantoin solutions was investigated by means of cyclic voltammetric measurement, scanning electron microscopy (SEM) and X-ray diffraction (XRD). Cyclic voltammetric studies indicate that the reduction process of silver electrodeposition is influenced by adding 2-butyne-1, 4-diol. Owing to its adsorption on the electrode surface, 2-butyne-1, 4-diol moderately hinders the mass transfer of the silver complexed ions from the bulk solution to the outer limit of the electrode double layer and affects the electrocrystallization step. Scanning electron microscopy analysis reveals that the presence of 2-butyne-1, 4-diol in the electrolyte is beneficial and the silver deposits obtained are smoother, more compact and more leveled. X-ray diffraction analysis of the silver deposits obtained at 0.5 g·L-1 2-butyne-1, 4-diol indicated that the (110) plane is the most preferred plane and is not affected by the presence of 2-butyne-1, 4-diol in the electrolyte.
基金Gansu Province Science and Technology Bureau Program Funds(144FKCA065)
文摘The title compound N1-(2-(4-bromo-2-nitrophenoxy)-2-dimethyl acyloxymethyl)-5-fluorouracil(C15H13BrFN3O7, Mr = 446.19) was synthesized and structurally characterized by ^1H-NMR, -(13)C-NMR, ESI-MS and single-crystal X-ray diffraction. The compound crystallizes in triclinic, space group P1, with a = 8.3325(6), b = 10.1808(13), c = 11.8194(16) A, α = 73.194(12), β= 72.351(9), γ = 89.509(8)o, V = 911.2(2) A^3, Z = 2, T = 300.79(10) K, μ(Cu Kα) = 3.578 mm^-1, Dc = 1.626 g/cm3, F(000) = 448.0, GOF = 1.060, 5723 reflections measured(8.232≤2θ≤139.592°), 3339 unique(Rint = 0.0184, Rsigma = 0.0254) which were used in all calculations. The final R = 0.0517(I 〉 2s(I)) and wR = 0.1494(all data). Hydrogen bonds and π-π interactions together stabilize the structure of the molecule. The preliminary biological test shows that the title compound has good antitumor activity against A549 in vitro and lower toxicity to normal cells.